A stabilized analog of Selank (tuftsin + Pro-Gly-Pro) with an N-terminal acetyl and C-terminal amide modification. The modifications block exopeptidase cleavage to extend intranasal and plasma half-life relative to the parent peptide. Studied for GABAergic anxiolytic activity and serotonergic/dopaminergic modulation; shares Selank's Russian origin and lacks FDA approval.
For research purposes only. Not medical advice.
Step One currently lists N-Acetyl Selank at $4.50/mg, the lowest indexed price across 2 tracked research peptide vendors.
N-Acetyl Selank ranges from $4.50/mg to $4.90/mg across 2 listings from 2 research peptide vendors, normalized to USD per milligram and refreshed daily.
2 research peptide vendors currently list N-Acetyl Selank on PeptideScouter. We track 2 active listings across size and kit variants.